The founders of Nahtlos AG José Näf and Michel Schmid with the textile-based electrodes for long-term ECGs in their laboratory in St. Gallen. Photo: Marlies Thurnheer
The founders of Nahtlos AG José Näf and Michel Schmid with the textile-based electrodes for long-term ECGs in their laboratory in St. Gallen. Photo: Marlies Thurnheer - Nahtlos, an Empa spin-off, has received 1 million Swiss francs in a first round of financing from a network of business angels from Switzerland and Liechtenstein and from the Startfeld Foundation. With this funding, Nahtlos aims to drive the market entry of its newly developed textile-based electrode for medical applications. Over the past two years, Nahtlos, an Empa spin-off, has developed novel textile-based electrodes for recording heart activity (electrocardiogram, ECG) - for example, to detect atrial fibrillation - and for electrostimulation therapies, for example, to preserve the muscle mass in paralyzed patients. Textile-based electrodes enable gentle and skin-friendly application, even if the electrodes have to be worn for several days or even weeks. The textile electrode is thus the first alternative to the gel electrode, which was developed 60 years ago and is still considered the standard for medical applications today. Nahtlos founder and former Empa researcher Michel Schmid and co-founder and business economist José Näf have further developed the textile-based technology, which was developed and patented at Empa in various projects funded by Innosuisse, among others.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
